Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease

Mielle Michaux1,2, Justin M Chan1,2, Luke Bergmann3

  • 1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, British Columbia Children's Hospital, University of British Columbia, Vancouver V6H 3V4, British Columbia, Canada.

Insights

Pediatric inflammatory bowel disease (IBD) clusters were found in British Columbia, linked to air pollution and agricultural pesticides. These environmental factors, along with ethnicity, influence pediatric IBD incidence.

Area of Science:

  • Environmental Epidemiology
  • Pediatric Gastroenterology
  • Spatial Analysis

Background:

  • Geographical clusters of inflammatory bowel disease (IBD) suggest environmental influences, but pediatric IBD (PIBD) spatial patterns in North America remain uncharacterized.
  • This study investigated geospatial clusters of PIBD in British Columbia (BC), Canada, hypothesizing associations with ethnicity and environmental exposures.

Purpose of the Study:

  • To identify spatial clusters of pediatric IBD (PIBD) in British Columbia.
  • To model the association between PIBD incidence patterns and population ethnicity, rurality, socioeconomic factors, and environmental exposures.

Main Methods:

  • Utilized a clinical registry of 1,183 pediatric patients diagnosed with IBD (age ≤ 16.9 years, 2001-2016) with valid postal codes.
  • Employed spatial cluster detection routines to identify high and low incidence areas.
  • Conducted an ecological analysis using Poisson rate models, assessing IBD, Crohn's disease (CD), and ulcerative colitis (UC) incidence against ethnicity, rurality, family size, income, green space, air pollution (PM2.5), UV light, and pesticide applications.

Main Results:

  • Identified PIBD, CD, and UC incidence hot spots in Metro Vancouver, southern Okanagan, and Vancouver Island, with cold spots in southeastern and northern BC.
  • Novel risk factors for PIBD included fine particulate matter (PM2.5) air pollution and agricultural petroleum oil pesticide application.
  • South Asian ethnicity was a risk factor, while Indigenous ethnicity, larger family size, and higher summer UV exposure showed protective effects for PIBD.

Conclusions:

  • Spatial clusters of pediatric IBD (PIBD) were identified in British Columbia, associated with both known and novel environmental determinants.
  • Fine particulate matter (PM2.5) air pollution and agricultural pesticide use emerged as significant novel risk factors requiring further investigation.
  • The findings underscore the role of environmental exposures and ethnicity in pediatric IBD etiology.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
299
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
357
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
223
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
155
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489